Apellis Pharmaceuticals, Inc. - COM (APLS)

Q2 2018 13F Holders as of 6/30/2018

Type / Class
Equity / COM
Number of holders
73
Total Shares
29.1M
Shares change
+12M
Total reported value, excl. options
$639M
Value change
+$266M
Put/Call ratio
0
Number of buys
66
Number of sells
-11
Price
$22.00
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.